Humoral immune response in Hepatitis B virus infections

Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?

Epidemiology and infection·2014

Comparative hepatitis A seroepidemiology in 10 European countries.

Epidemiology and infection·2012

Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers.

Journal of viral hepatitis·2010

Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.

Epidemiology and infection·2010

The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries.

Epidemiology and infection·2008

Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.

Journal of medical virology·2008

Persistent candidemia matters: risk factors and clinical outcomes in a retrospective matched cohort study.

Infection·2026

A retrospective study of alternative antibiotics for prophylaxis of the Group B Streptococcus maternal-fetal disease.

Infection·2026

Outcomes and associated risk factors among hospitalisations attributed to invasive group A streptococcal disease in Northern Queensland, Australia: a 21-year population-based data linkage study.

Infection·2026

Impact of time from symptom onset to diagnosis in infective endocarditis: insights from the nationwide NIDUS registry.

Infection·2026

Clinical utility of time to positivity in candidemia: prognostic limitations and species-specific implications.

Infection·2026

Immunosuppressive medication exposure and risk of invasive fungal and nontuberculous mycobacterial infections following TNF-α inhibitor initiation: a time-varying analysis.

Infection·2026

Pre-Pandemic Scientific Insights into Influenza A (H3N2): Viral Evolution, Host Responses, and Evidence-Based Preventive Strategies.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

European journal of pharmacology·2026

Serum 25(OH)D concentrations are differentially associated with innate and adaptive immune cell markers, with threshold effects near 40 ng/mL: A cross-sectional study.

Nutrition research (New York, N.Y.)·2026

Hesperetin alleviates DSS induced colitis by inhibiting TLR2/NF-κB and restoring intestinal barrier.

Biochemical and biophysical research communications·2026

Mucosal adjuvant activity of a PAR-2-activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime-boost influenza vaccination model.

Vaccine·2026

Preparation and functional evaluation of an alginate-targeted monoclonal antibody against Pseudomonas aeruginosa.

Vaccine·2026

Related Experiment Videos

Humoral immune response in Hepatitis B virus infections

Related Concept Videos

Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?

Comparative hepatitis A seroepidemiology in 10 European countries.

Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers.

Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.

The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries.

Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.

Persistent candidemia matters: risk factors and clinical outcomes in a retrospective matched cohort study.

A retrospective study of alternative antibiotics for prophylaxis of the Group B Streptococcus maternal-fetal disease.

Outcomes and associated risk factors among hospitalisations attributed to invasive group A streptococcal disease in Northern Queensland, Australia: a 21-year population-based data linkage study.

Impact of time from symptom onset to diagnosis in infective endocarditis: insights from the nationwide NIDUS registry.

Clinical utility of time to positivity in candidemia: prognostic limitations and species-specific implications.

Immunosuppressive medication exposure and risk of invasive fungal and nontuberculous mycobacterial infections following TNF-α inhibitor initiation: a time-varying analysis.

Pre-Pandemic Scientific Insights into Influenza A (H3N2): Viral Evolution, Host Responses, and Evidence-Based Preventive Strategies.

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

Serum 25(OH)D concentrations are differentially associated with innate and adaptive immune cell markers, with threshold effects near 40 ng/mL: A cross-sectional study.

Hesperetin alleviates DSS induced colitis by inhibiting TLR2/NF-κB and restoring intestinal barrier.

Mucosal adjuvant activity of a PAR-2-activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime-boost influenza vaccination model.

Preparation and functional evaluation of an alginate-targeted monoclonal antibody against Pseudomonas aeruginosa.

Related Experiment Videos

Humoral immune response in Hepatitis B virus infections

Related Concept Videos

Related Articles